TCL Archive NSABP Objects to “Closed Process” For Review Of P-4 Breast Cancer Chemoprevention Trial. April 20, 2007
TCL Archive In Brief: Preyer, Waxman Battle Over Chairmanship Of Health Group; Amos To Head Mas. ACS January 12, 1979
TCL Archive In odd aftermath of FDA Commissioner Mark McClellan’s lecture, NCI Director Andrew von Eschenbach forwards the commissioner’s thank-you note to 3,000 NCI staff. The email blast follows FDA’s return of NCI’s gift to McClellan. March 12, 2004
